Showing results (241-250 of 284) with videos related to
Sort By:
Pageof 29
Emerging Infectious Diseases|May 19, 2016
Antibody Response and Disease Severity in Healthcare Worker MERS SurvivorsAbeer N Alshukairi, Imran Khalid, Waleed A Ahmed, et al.Vaccine|February 27, 2021
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety dataFlor M Munoz, Jakob P Cramer, Cornelia L Dekker, et al.Proceedings of the National Academy of Sciences of the United States of America|January 7, 2026
Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infectionAbhishek Kumar Verma, Lu Tan, Noah Schuster, et al.JCI Insight|March 5, 2019
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infectionLi Liu, Qiang Wei, Qingqing Lin, et al.Emerging Infectious Diseases|December 6, 2024
Ongoing Evolution of Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, 2023-2024Ahmed M Hassan, Barbara Mühlemann, Tagreed L Al-Subhi, et al.Antiviral Research|November 29, 2016
Passive immunotherapy for Middle East Respiratory Syndrome coronavirus infection with equine immunoglobulin or immunoglobulin fragments in a mouse modelYongkun Zhao, Chong Wang, Boning Qiu, et al.Biorxiv : the Preprint Server for Biology|June 19, 2024
A predominately pulmonary activation of complement in a mouse model of severe COVID-19Peter J Szachowicz, Christine Wohlford-Lenane, Cobey J Heinen, et al.Proceedings of the National Academy of Sciences of the United States of America|July 29, 2015
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirusDavide Corti, Jincun Zhao, Mattia Pedotti, et al.Journal of Medicinal Chemistry|December 6, 2021
Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based StudiesChamandi S Dampalla, Athri D Rathnayake, Krishani Dinali Perera, et al.Biorxiv : the Preprint Server for Biology|April 28, 2021
Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19Lok-Yin Roy Wong, Jian Zheng, Kevin Wilhelmsen, et al.Pageof 29